in Vitro Diagnostic Reagent Supplier – COVID-19 Detection reagent equipment – CILIANG
in Vitro Diagnostic Reagent Supplier – COVID-19 Detection reagent equipment – CILIANG Detail:
Neutralizing antibody against SARS-CoV-2 can resist human immune SARS-CoV-2 infection.
Therefore, the detection of neutralizing antibodies against SARS-CoV-2 has important clinical significance for patients with convalescent infection or for vaccination of SARS-CoV-2 vaccine.
The SARS-CoV-2 Neutralizing Antibody Test Kit is for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human serum, plasma or whole blood sample. The test kit is intended for use outside the body only (in vitro diagnostic use) for professional use and should not be used to diagnose acute SARS-CoV-2 infection.
Analyzer
Test Kit
Product
Method
Specimen type
Specimen volume
Test time
Package size
Storage
SARS-CoV-2 Neutralizing Antibody Test Kit
Fluorescence Immunochromatography
Serum, plasma or whole blood sample
25µl
10 minutes
25 pcs/box; 50 pcs/box
4℃~30℃
Product detail pictures:
Related Product Guide:
We retain improving upon and perfecting our items and repair. At the same time, we perform actively to do research and progress for in Vitro Diagnostic Reagent Supplier – COVID-19 Detection reagent equipment – CILIANG, The product will supply to all over the world, such as: Riyadh, Greek, Korea, We believe that good business relationships will lead to mutual benefits and improvement for both parties. We have established long-term and successful cooperative relationships with many customers through their confidence in our customized services and integrity in doing business. We also enjoy a high reputation through our good performance. Better performance will be expected as our principle of integrity. Devotion and Steadiness will remain as ever.
By Chris from Jordan - 2017.01.28 18:53
It's really lucky to find such a professional and responsible manufacturer, the product quality is good and delivery is timely, very nice.
By Catherine from United States - 2018.09.19 18:37
